133 related articles for article (PubMed ID: 34900801)
1. Increased circulating level of CTRP15 in patients with type 2 diabetes mellitus and its relation with inflammation and insulin resistance.
Mohassel Azadi S; Shateri H; Mohammadi M; Fadaei R; Sajedi F; Ziamajidi N
J Diabetes Metab Disord; 2021 Dec; 20(2):1499-1504. PubMed ID: 34900801
[TBL] [Abstract][Full Text] [Related]
2. Plasma Complement C1q/tumor necrosis factor-related protein 15 concentration is associated with polycystic ovary syndrome.
Vatannejad A; Fadaei R; Salimi F; Fouani FZ; Habibi B; Shapourizadeh S; Eivazi S; Eivazi S; Sadeghi A; Moradi N
PLoS One; 2022; 17(6):e0263658. PubMed ID: 35700181
[TBL] [Abstract][Full Text] [Related]
3. Higher serum level of CTRP15 in patients with coronary artery disease is associated with disease severity, body mass index and insulin resistance.
Shokoohi Nahrkhalaji A; Ahmadi R; Fadaei R; Panahi G; Razzaghi M; Fallah S
Arch Physiol Biochem; 2022 Feb; 128(1):276-280. PubMed ID: 31608708
[TBL] [Abstract][Full Text] [Related]
4. Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines.
Dadmanesh M; Aghajani H; Fadaei R; Ghorban K
PLoS One; 2018; 13(9):e0204180. PubMed ID: 30212581
[TBL] [Abstract][Full Text] [Related]
5. The impacts of C1q/TNF-related protein-15 and adiponectin on Interleukin-6 and tumor necrosis factor-α in primary macrophages of patients with coronary artery diseases.
Ahmadi R; Fadaei R; Shokoohi Nahrkhalaji A; Panahi G; Fallah S
Cytokine; 2021 Jun; 142():155470. PubMed ID: 33676229
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis.
Liu C; Feng X; Li Q; Wang Y; Li Q; Hua M
Cytokine; 2016 Oct; 86():100-109. PubMed ID: 27498215
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy.
Goodarzi G; Setayesh L; Fadaei R; Khamseh ME; Aliakbari F; Hosseini J; Moradi N
Mol Biol Rep; 2021 Jul; 48(7):5443-5450. PubMed ID: 34304366
[TBL] [Abstract][Full Text] [Related]
8. Circulating C1q/TNF-related protein isoform 15 is a marker for the presence of metabolic syndrome.
Mi Q; Li Y; Wang M; Yang G; Zhao X; Liu H; Zheng H; Li L
Diabetes Metab Res Rev; 2019 Jan; 35(1):e3085. PubMed ID: 30303269
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6.
Fadaei R; Bagheri N; Heidarian E; Nouri A; Hesari Z; Moradi N; Ahmadi A; Ahmadi R
Cytokine; 2020 Jan; 125():154832. PubMed ID: 31479874
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function.
Moradi N; Fadaei R; Khamseh ME; Nobakht A; Rezaei MJ; Aliakbary F; Vatannejad A; Hosseini J
PLoS One; 2019; 14(4):e0215617. PubMed ID: 31009504
[TBL] [Abstract][Full Text] [Related]
11. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
Daniele G; Guardado Mendoza R; Winnier D; Fiorentino TV; Pengou Z; Cornell J; Andreozzi F; Jenkinson C; Cersosimo E; Federici M; Tripathy D; Folli F
Acta Diabetol; 2014 Feb; 51(1):123-31. PubMed ID: 24370923
[TBL] [Abstract][Full Text] [Related]
12. Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease.
Moradi N; Fadaei R; Emamgholipour S; Kazemian E; Panahi G; Vahedi S; Saed L; Fallah S
PLoS One; 2018; 13(1):e0192159. PubMed ID: 29381773
[TBL] [Abstract][Full Text] [Related]
13. Decreased serum levels of CTRP12/adipolin in patients with coronary artery disease in relation to inflammatory cytokines and insulin resistance.
Fadaei R; Moradi N; Kazemi T; Chamani E; Azdaki N; Moezibady SA; Shahmohamadnejad S; Fallah S
Cytokine; 2019 Jan; 113():326-331. PubMed ID: 30337217
[TBL] [Abstract][Full Text] [Related]
14. Oxidative DNA damage is associated with inflammatory response, insulin resistance and microvascular complications in type 2 diabetes.
Tatsch E; De Carvalho JA; Hausen BS; Bollick YS; Torbitz VD; Duarte T; Scolari R; Duarte MM; Londero SW; Vaucher RA; Premaor MO; Comim FV; Moresco RN
Mutat Res; 2015 Dec; 782():17-22. PubMed ID: 26520687
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of C1q/TNF-related protein-3 in inflammatory bowel disease patients and its inverse association with inflammatory cytokines and insulin resistance.
Mohamadinarab M; Ahmadi R; Gholamrezayi A; Rahvar F; Naghdalipour M; Setayesh L; Moradi N; Fadaei R; Chamani E; Tavakoli T; Esteghamati A
IUBMB Life; 2020 Aug; 72(8):1698-1704. PubMed ID: 32311832
[TBL] [Abstract][Full Text] [Related]
16. Elevated Serum TNF-
Alzamil H
J Obes; 2020; 2020():5076858. PubMed ID: 32089876
[TBL] [Abstract][Full Text] [Related]
17. Resistin is Associated with Inflammation and Renal Function, but not with Insulin Resistance in Type 2 Diabetes.
Rzepa Ł; Peller M; Eyileten C; Rosiak M; Kondracka A; Mirowska-Guzel D; Opolski G; Filipiak KJ; Postuła M; Kapłon-Cieslicka A
Horm Metab Res; 2021 Jul; 53(7):478-484. PubMed ID: 34169498
[TBL] [Abstract][Full Text] [Related]
18. The Variation and Correlation of Serum Adiponectin, Nesfatin-1, IL-6, and TNF-α Levels in Prediabetes.
Huang K; Liang Y; Ma Y; Wu J; Luo H; Yi B
Front Endocrinol (Lausanne); 2022; 13():774272. PubMed ID: 35311231
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes.
Zhang X; Li ZZ; Liu DF; Xu X; Mei ZC; Shen W
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):631-6. PubMed ID: 19076162
[TBL] [Abstract][Full Text] [Related]
20. Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus.
Fadaei R; Moradi N; Baratchian M; Aghajani H; Malek M; Fazaeli AA; Fallah S
PLoS One; 2016; 11(12):e0168773. PubMed ID: 28033351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
